Page last updated: 2024-08-23

colforsin and ponatinib

colforsin has been researched along with ponatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kirken, RA; Oaxaca, DM; Rodriguez, G; Ross, JA; Staniswalis, JG; Yang-Reid, SA	1

Other Studies

1 other study(ies) available for colforsin and ponatinib

Article	Year
Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:9 Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colforsin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HEK293 Cells; Hep G2 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Protein Kinase Inhibitors; Pyridazines; src-Family Kinases	2016

Article

Year

Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:9

Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colforsin; Drug Resistance, Neoplasm; Drug Synergism; Fusion Proteins, bcr-abl; HEK293 Cells; Hep G2 Cells; Humans; Imatinib Mesylate; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; Protein Kinase Inhibitors; Pyridazines; src-Family Kinases

2016